COMPARATIVE BIOAVAILABILITY OF DIFFERENT PREPARATIONS OF PARACETAMOL ADMINISTERED IN SINGLE DOSES.WOJCICKI J; GAWRONSKA SZKLARZ B; KAZIMIERCZYK J et al.1977; ZBL. PHARM. PHARMAKOTHERAP. LAB.-DIAGNOST.; DTSCH.; DA. 1977; VOL. 116; NO 4; PP. 355-359; BIBL. 5 REF.Article

BIODISPONIBILITE DU N-ACETYL P AMINOPHENOLWOJCICKI J; GAWRONSKA SZKLARZ B; KAZIMIERCZYK J et al.1977; ROCZ. POMORSK. AKAD. MED. KAROLA SWIERCZEWSKIEGO SZCZECINIE; POLSKA; DA. 1977; VOL. 23; PP. 245-253; ABS. RUSSE ANGL.; BIBL. 1/2 P.Article

EFFECT OF PAPAVERINE AND ATROPINE ON PHARMACOKINETICS OF PARACETAMOL ADMINISTERED ORALLYWOJCICKI J; KAZMIERCZYK J; GAWRONSKA SZKLARZ B et al.1979; POL. J. PHARMACOL. PHARM.; ISSN 0301-0244; POL; DA. 1979; VOL. 31; NO 3; PP. 239-243; ABS. POL; BIBL. 6 REF.Article

EFFECT OF UNILATERAL NEPHRECTOMY ON THE PHARMACOKINETICS OF ROLITETRACYCLINE IN RABBITSWOJCICKI J; GAWRONSKA SZKLARZ B; KARDEL MIZERSKA T et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 9; PP. 1456-1458; ABS. GER; BIBL. 9 REF.Article

Comparative pharmacokinetics of doxycycline and oxytetracycline in patients with hyperlipidemiaWOJCICKI, J; KALINOWSKI, W; GAWRONSKA-SZKLARZ, B et al.Arzneimittel-Forschung. 1985, Vol 35, Num 6, pp 991-993, issn 0004-4172Article

THE EFFECT OF A SINGLE DOSE OF ETHANOL ON PHARMACOKINETICS OF PARACETAMOLWOJCICKI J; BASKIEWICZ Z; GAWRONSKA SZKLARZ B et al.1978; POLISH J. PHARMACOL. PHARM.; POL; DA. 1978; VOL. 30; NO 6; PP. 749-753; ABS. POL; BIBL. 14 REF.Article

Natural (-)- and unnatural (+)-enantiomers of morphine: comparative metabolism and effect of morphine and phenobarbital treatmentRANE, A; GAWRONSKA-SZKLARZ, B; SVENSSON, J.-O et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 234, Num 3, pp 761-765, issn 0022-3565Article

Association of cytokine gene polymorphisms and the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasonePAWLIK, A; BASKIEWICZ-MASIUK, M; MACHALINSKI, B et al.International immunopharmacology. 2006, Vol 6, Num 3, pp 351-357, issn 1567-5769, 7 p.Article

Involvement of P-gp in the process of apoptosis in peripheral blood mononuclear cellsPAWLIK, A; BASKIEWICZ-MASIUK, M; MACHALINSKI, B et al.International immunopharmacology. 2005, Vol 5, Num 5, pp 821-828, issn 1567-5769, 8 p.Article

The influence of N-acetyl-transferase 2 polymorphism on rheumatoid arthritis activityPAWLIK, A; OSTANEK, L; BRZOSKO, I et al.Clinical and experimental rheumatology (Testo stampato). 2004, Vol 22, Num 1, pp 99-102, issn 0392-856X, 4 p.Article

The FcyRIIa polymorphism in children with atopic diseasesPAWLIK, A; CARLSSON, L; MEISEL, P et al.International archives of allergy and immunology. 2004, Vol 133, Num 3, pp 233-238, issn 1018-2438, 6 p.Article

Relationship between acetylation polymorphism and risk of atopic diseasesGAWRONSKA-SZKLARZ, B; LUSZAWSKA-KUTRZEBA, T; CZAJA-BULSA, G et al.Clinical pharmacology and therapeutics. 1999, Vol 65, Num 5, pp 562-569, issn 0009-9236Article

TNF-α: 308 promoter polymorphism in patients with rheumatoid arthritisPAWLIK, A; FLORCZAK, M; OSTANEK, L et al.Scandinavian journal of rheumatology. 2005, Vol 34, Num 1, pp 22-26, issn 0300-9742, 5 p.Article

IL1β+3953 exon 5 and IL-2 -330 promoter polymorphisms in patients with rheumatoid arthritisPAWLIK, A; KURZAWSKI, M; FLORCZAK, M et al.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 2, pp 159-164, issn 0392-856X, 6 p.Article

Il-6 promoter polymorphism in patients with rheumatoid arthritisPAWLIK, A; WRZESNIEWSKA, J; FLORCZAK, M et al.Scandinavian journal of rheumatology. 2005, Vol 34, Num 2, pp 109-113, issn 0300-9742, 5 p.Article

Effect of unilateral nephrectomy on the pharmacokinetics of amikacin in humansDROZDZIK, M; DOMANSKI, L; WOJCICKI, J et al.Journal of pharmacy and pharmacology. 2002, Vol 54, Num 4, pp 509-514, issn 0022-3573Article

The correlation between FcγRIIA polymorphism and renal allograft survivalPAWLIK, A; FLORCZAK, M; BAK, L et al.Transplantation proceedings. 2002, Vol 34, Num 8, pp 3138-3139, issn 0041-1345, 2 p.Article

Studies on the pharmacokinetics and pharmacodynamics of propranolol in hyperlipidemiaWOJCICKI, J; SULZYC-BIELICKA, V; KUTRZEBA, J et al.Journal of clinical pharmacology. 1999, Vol 39, Num 8, pp 826-833, issn 0091-2700Article

IL-2 and TNF-α promoter polymorphisms in patients with acute kidney graft rejectionPAWLIK, A; DOMANSKI, L; ROZANSKI, J et al.Transplantation proceedings. 2005, Vol 37, Num 5, pp 2041-2043, issn 0041-1345, 3 p.Article

CYP2D6 and GSTM1 genotypes in a Polish populationGAWRONSKA-SZKLARZ, B; WOJCICKI, M; KUPRIANOWICZ, A et al.European journal of clinical pharmacology. 1999, Vol 55, Num 5, pp 389-392, issn 0031-6970Article

Cytokine gene polymorphisms in patients with delayed renal graft functionPAWLIK, A; DOMANSKI, L; ROZANSKI, J et al.Dialysis & transplantation. 2005, Vol 34, Num 9, pp 602-606, issn 0090-2934, 5 p., 646 [6 p.]Article

Pharmacokinetics of intravenously administered digoxin and histopathological picture in rabbits with experimental bile duct obstructionWOJCICKI, M; DROZDZIK, M; SULIKOWSKI, T et al.European journal of pharmaceutical sciences. 2000, Vol 11, Num 3, pp 215-222, issn 0928-0987Article

Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosisSKRETKOWICZ, K; SKRETKOWICZ, J; GAWRONSKA-SZKLARZ, B et al.European journal of clinical pharmacology. 2005, Vol 60, Num 11, pp 773-778, issn 0031-6970, 6 p.Article

Pharmacokinetics of lidocaine and its major metabolite-monoethylglycinexylidide (MEGX) in rabbits with experimental common bile duct obstructionWOJCICKI, J; SULIKOWSKI, T; WOJCICKI, M et al.European journal of drug metabolism and pharmacokinetics. 1995, Vol 20, Num 2, pp 119-123, issn 0378-7966Article

Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative studyWOJCICKI, J; WOJCIENCHOWSKI, G; WOJCICKI, M et al.European journal of clinical pharmacology. 2000, Vol 56, Num 1, pp 75-79, issn 0031-6970Article